CCWYF (SoftMedX Healthcare) Stock Based Compensation: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CCWYF SoftMedX Healthcare Ltd CCWYF
54 GF Score
Price $0.70
GF Value $2.99
! 4 Warning Signs
View Full Analysis

What is SoftMedX Healthcare Stock Based Compensation?

SoftMedX Healthcare CCWYF 54 Stock Based Compensation is $0.00 Mil as of Jun. 2026. GuruFocus rates CCWYF with a GF Score™ of 54/100 and a GF Value™ of $2.99. The stock has 4 warning signs investors should review.

SoftMedX Healthcare's Stock Based Compensation for the six months ended in Jun. 2026 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil.

SoftMedX Healthcare Stock Based Compensation Related Terms

SoftMedX Healthcare Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for SoftMedX Healthcare's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SoftMedX Healthcare Stock Based Compensation Chart

SoftMedX Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SoftMedX Healthcare Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CCWYF
54GF Score
SoftMedX Healthcare Ltd CCWYF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SoftMedX Healthcare Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
SoftMedX Healthcare (CCWYF) has a Stock Based Compensation of $0.00 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for SoftMedX Healthcare and its competitors.
Is SoftMedX Healthcare's Stock Based Compensation too high?
SoftMedX Healthcare's current Stock Based Compensation is $0.00 Mil. Overall, SoftMedX Healthcare has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's Stock Based Compensation compare to HCA and THC?
SoftMedX Healthcare's Stock Based Compensation of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for SoftMedX Healthcare and its competitors. SoftMedX Healthcare's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
SoftMedX Healthcare (CCWYF) has a current Stock Based Compensation of $0.00 Mil. The stock's GF Value™ is $2.99, compared to a current price of $0.70 — trading 76.6% below its estimated fair value. The current Stock Based Compensation is $0.00 Mil. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For SoftMedX Healthcare (CCWYF), the current Stock Based Compensation is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SoftMedX Healthcare (CCWYF) Overvalued in 2026?

Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued. The current stock price of $0.70 is trading 76.6% below its estimated GF Value™ of $2.99.

Key valuation signals for CCWYF:

  • Stock Based Compensation: $0.00 Mil
  • GF Value™: $2.99 vs. price of $0.70 (76.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the CCWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SoftMedX Healthcare Business Description

Other Exchanges 00648:Hong Kong
Address 8-12 Hennessy Road, 8th Floor, China Hong Kong Tower, Wanchai, Hong Kong, HKG
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score

Get the complete analysis for CCWYF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price
$2.99
GF Value